Leramistat

Musculoskeletal Repair

Disease-resolution is possible

"Our approach operates above inflammatory signalling pathways to provide holistic cellular moderation and resolution of disease states, and creates a new therapeutic life-changing opportunity for patients.
"

Lisa Patel

Chief Executive Officer

Our innovative drug is the first of its kind to go into clinical trials. We are at the most exciting stage of development, as we build our pipeline and expand the value and application of MBS2320.

Latest news

Latest news shape
Istesso
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

More information about our Privacy Policy